title: Olanzapine postinjection delirium/sedation syndrome: an unrecognized diagnosis in the emergency department.
authors.affiliation: Department of Toxicological and Medical Intensive Care, Paris-Diderot University, Paris, France.
authors.forename: Dominique
authors.initials: D
authors.lastname: Vodovar
authors.affiliation: Department of Toxicological and Medical Intensive Care, Paris-Diderot University, Paris, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Malissin
authors.affiliation: Department of Toxicological and Medical Intensive Care, Paris-Diderot University, Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Deye
authors.affiliation: Department of Toxicological and Medical Intensive Care, Paris-Diderot University, Paris, France.
authors.forename: Frédéric J
authors.initials: FJ
authors.lastname: Baud
authors.affiliation: Department of Toxicological and Medical Intensive Care, Paris-Diderot University, Paris, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Mégarbane
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D003693:Delirium / Q000139:chemically induced*; D004401:Dysarthria / Q000139:chemically induced; D004636:Emergency Service, Hospital; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy; D013577:Syndrome
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D001569:Benzodiazepines; D000077152:Olanzapine